The Nuclear Medicine/Radiopharmaceuticals market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Nuclear Medicine/Radiopharmaceuticals industrial chain, this report mainly elaborates the definition, types, applications and major players of Nuclear Medicine/Radiopharmaceuticals market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2019-2024), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Nuclear Medicine/Radiopharmaceuticals market.
The Nuclear Medicine/Radiopharmaceuticals market can be split based on product types, major applications, and important regions.
Major Players in Nuclear Medicine/Radiopharmaceuticals market are:
Cardinal Health
Nordion
IBA Molecular Imaging
Mallinckrodt PLC
GE Healthcare
Bracco Imaging S.P.A
Advanced Accelerator Applications S.A.
Lantheus Medical Imaging
Bayer Healthcare
Eczcibasi-Monrol Nuclear Products
Major Regions that plays a vital role in Nuclear Medicine/Radiopharmaceuticals market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
Most important types of Nuclear Medicine/Radiopharmaceuticals products covered in this report are:
Diagnosis
Therapeutics
Most widely used downstream fields of Nuclear Medicine/Radiopharmaceuticals market covered in this report are:
Alpha radiation therapy
Beta radiation therapy
Brachytherapy
There are 13 Chapters to thoroughly display the Nuclear Medicine/Radiopharmaceuticals market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.
Chapter 1: Nuclear Medicine/Radiopharmaceuticals Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.
Chapter 2: Nuclear Medicine/Radiopharmaceuticals Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.
Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Nuclear Medicine/Radiopharmaceuticals.
Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Nuclear Medicine/Radiopharmaceuticals.
Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Nuclear Medicine/Radiopharmaceuticals by Regions (2014-2019).
Chapter 6: Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import by Regions (2014-2019).
Chapter 7: Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis by Regions.
Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Nuclear Medicine/Radiopharmaceuticals.
Chapter 9: Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast by Type and Application (2019-2024).
Chapter 10: Market Analysis and Forecast by Regions (2019-2024).
Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.
Chapter 12: Market Conclusion of the Whole Report.
Chapter 13: Appendix Such as Methodology and Data Resources of This Research.
Global Nuclear Medicine/Radiopharmaceuticals Industry Market Research Report 1 Nuclear Medicine/Radiopharmaceuticals Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Nuclear Medicine/Radiopharmaceuticals 1.3 Nuclear Medicine/Radiopharmaceuticals Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Global Nuclear Medicine/Radiopharmaceuticals Value ($) and Growth Rate from 2014-2024 1.4 Market Segmentation 1.4.1 Types of Nuclear Medicine/Radiopharmaceuticals 1.4.2 Applications of Nuclear Medicine/Radiopharmaceuticals 1.4.3 Research Regions 1.4.3.1 North America Nuclear Medicine/Radiopharmaceuticals Production Value ($) and Growth Rate (2014-2019) 1.4.3.2 Europe Nuclear Medicine/Radiopharmaceuticals Production Value ($) and Growth Rate (2014-2019) 1.4.3.3 China Nuclear Medicine/Radiopharmaceuticals Production Value ($) and Growth Rate (2014-2019) 1.4.3.4 Japan Nuclear Medicine/Radiopharmaceuticals Production Value ($) and Growth Rate (2014-2019) 1.4.3.5 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Production Value ($) and Growth Rate (2014-2019) 1.4.3.6 India Nuclear Medicine/Radiopharmaceuticals Production Value ($) and Growth Rate (2014-2019) 1.4.3.7 South America Nuclear Medicine/Radiopharmaceuticals Production Value ($) and Growth Rate (2014-2019) 1.5 Market Dynamics 1.5.1 Drivers 1.5.1.1 Emerging Countries of Nuclear Medicine/Radiopharmaceuticals 1.5.1.2 Growing Market of Nuclear Medicine/Radiopharmaceuticals 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Regions 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Nuclear Medicine/Radiopharmaceuticals Analysis 2.2 Major Players of Nuclear Medicine/Radiopharmaceuticals 2.2.1 Major Players Manufacturing Base and Market Share of Nuclear Medicine/Radiopharmaceuticals in 2018 2.2.2 Major Players Product Types in 2018 2.3 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Structure Analysis 2.3.1 Production Process Analysis 2.3.2 Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals 2.3.3 Raw Material Cost of Nuclear Medicine/Radiopharmaceuticals 2.3.4 Labor Cost of Nuclear Medicine/Radiopharmaceuticals 2.4 Market Channel Analysis of Nuclear Medicine/Radiopharmaceuticals 2.5 Major Downstream Buyers of Nuclear Medicine/Radiopharmaceuticals Analysis 3 Global Nuclear Medicine/Radiopharmaceuticals Market, by Type 3.1 Global Nuclear Medicine/Radiopharmaceuticals Value ($) and Market Share by Type (2014-2019) 3.2 Global Nuclear Medicine/Radiopharmaceuticals Production and Market Share by Type (2014-2019) 3.3 Global Nuclear Medicine/Radiopharmaceuticals Value ($) and Growth Rate by Type (2014-2019) 3.4 Global Nuclear Medicine/Radiopharmaceuticals Price Analysis by Type (2014-2019) 4 Nuclear Medicine/Radiopharmaceuticals Market, by Application 4.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Market Share by Application (2014-2019) 4.2 Downstream Buyers by Application 4.3 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate by Application (2014-2019) 5 Global Nuclear Medicine/Radiopharmaceuticals Production, Value ($) by Region (2014-2019) 5.1 Global Nuclear Medicine/Radiopharmaceuticals Value ($) and Market Share by Region (2014-2019) 5.2 Global Nuclear Medicine/Radiopharmaceuticals Production and Market Share by Region (2014-2019) 5.3 Global Nuclear Medicine/Radiopharmaceuticals Production, Value ($), Price and Gross Margin (2014-2019) 5.4 North America Nuclear Medicine/Radiopharmaceuticals Production, Value ($), Price and Gross Margin (2014-2019) 5.5 Europe Nuclear Medicine/Radiopharmaceuticals Production, Value ($), Price and Gross Margin (2014-2019) 5.6 China Nuclear Medicine/Radiopharmaceuticals Production, Value ($), Price and Gross Margin (2014-2019) 5.7 Japan Nuclear Medicine/Radiopharmaceuticals Production, Value ($), Price and Gross Margin (2014-2019) 5.8 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Production, Value ($), Price and Gross Margin (2014-2019) 5.9 India Nuclear Medicine/Radiopharmaceuticals Production, Value ($), Price and Gross Margin (2014-2019) 5.10 South America Nuclear Medicine/Radiopharmaceuticals Production, Value ($), Price and Gross Margin (2014-2019) 6 Global Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import by Regions (2014-2019) 6.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption by Regions (2014-2019) 6.2 North America Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019) 6.3 Europe Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019) 6.4 China Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019) 6.5 Japan Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019) 6.6 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019) 6.7 India Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019) 6.8 South America Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019) 7 Global Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis by Regions 7.1 North America Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis 7.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis 7.3 China Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis 7.4 Japan Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis 7.5 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis 7.6 India Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis 7.7 South America Nuclear Medicine/Radiopharmaceuticals Market Status and SWOT Analysis 8 Competitive Landscape 8.1 Competitive Profile 8.2 Cardinal Health 8.2.1 Company Profiles 8.2.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.2.3 Cardinal Health Production, Value ($), Price, Gross Margin 2014-2019 8.2.4 Cardinal Health Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.3 Nordion 8.3.1 Company Profiles 8.3.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.3.3 Nordion Production, Value ($), Price, Gross Margin 2014-2019 8.3.4 Nordion Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.4 IBA Molecular Imaging 8.4.1 Company Profiles 8.4.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.4.3 IBA Molecular Imaging Production, Value ($), Price, Gross Margin 2014-2019 8.4.4 IBA Molecular Imaging Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.5 Mallinckrodt PLC 8.5.1 Company Profiles 8.5.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.5.3 Mallinckrodt PLC Production, Value ($), Price, Gross Margin 2014-2019 8.5.4 Mallinckrodt PLC Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.6 GE Healthcare 8.6.1 Company Profiles 8.6.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.6.3 GE Healthcare Production, Value ($), Price, Gross Margin 2014-2019 8.6.4 GE Healthcare Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.7 Bracco Imaging S.P.A 8.7.1 Company Profiles 8.7.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.7.3 Bracco Imaging S.P.A Production, Value ($), Price, Gross Margin 2014-2019 8.7.4 Bracco Imaging S.P.A Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.8 Advanced Accelerator Applications S.A. 8.8.1 Company Profiles 8.8.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.8.3 Advanced Accelerator Applications S.A. Production, Value ($), Price, Gross Margin 2014-2019 8.8.4 Advanced Accelerator Applications S.A. Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.9 Lantheus Medical Imaging 8.9.1 Company Profiles 8.9.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.9.3 Lantheus Medical Imaging Production, Value ($), Price, Gross Margin 2014-2019 8.9.4 Lantheus Medical Imaging Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.10 Bayer Healthcare 8.10.1 Company Profiles 8.10.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.10.3 Bayer Healthcare Production, Value ($), Price, Gross Margin 2014-2019 8.10.4 Bayer Healthcare Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 8.11 Eczcibasi-Monrol Nuclear Products 8.11.1 Company Profiles 8.11.2 Nuclear Medicine/Radiopharmaceuticals Product Introduction 8.11.3 Eczcibasi-Monrol Nuclear Products Production, Value ($), Price, Gross Margin 2014-2019 8.11.4 Eczcibasi-Monrol Nuclear Products Market Share of Nuclear Medicine/Radiopharmaceuticals Segmented by Region in 2018 9 Global Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast by Type and Application 9.1 Global Nuclear Medicine/Radiopharmaceuticals Market Value ($) & Volume Forecast, by Type (2019-2024) 9.1.1 Diagnosis Market Value ($) and Volume Forecast (2019-2024) 9.1.2 Therapeutics Market Value ($) and Volume Forecast (2019-2024) 9.2 Global Nuclear Medicine/Radiopharmaceuticals Market Value ($) & Volume Forecast, by Application (2019-2024) 9.2.1 Alpha radiation therapy Market Value ($) and Volume Forecast (2019-2024) 9.2.2 Beta radiation therapy Market Value ($) and Volume Forecast (2019-2024) 9.2.3 Brachytherapy Market Value ($) and Volume Forecast (2019-2024) 10 Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast by Region 10.1 North America Market Value ($) and Consumption Forecast (2019-2024) 10.2 Europe Market Value ($) and Consumption Forecast (2019-2024) 10.3 China Market Value ($) and Consumption Forecast (2019-2024) 10.4 Japan Market Value ($) and Consumption Forecast (2019-2024) 10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2019-2024) 10.6 India Market Value ($) and Consumption Forecast (2019-2024) 10.7 South America Market Value ($) and Consumption Forecast (2019-2024) 11 New Project Feasibility Analysis 11.1 Industry Barriers and New Entrants SWOT Analysis 11.2 Analysis and Suggestions on New Project Investment 12 Research Finding and Conclusion 13 Appendix 13.1 Discussion Guide 13.2 Knowledge Store: Maia Subscription Portal 13.3 Research Data Source 13.4 Research Assumptions and Acronyms Used
Nuclear MedicineRadiopharmaceuticals Industry
Nuclear MedicineRadiopharmaceuticals Industry
×